Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to $44.1 million.

  • Agios Pharmaceuticals' Prepaid Assets rose 987.18% to $44.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $44.1 million, marking a year-over-year increase of 987.18%. This contributed to the annual value of $44.1 million for FY2025, which is 987.18% up from last year.
  • Agios Pharmaceuticals' Prepaid Assets amounted to $44.1 million in Q4 2025, which was up 987.18% from $43.2 million recorded in Q3 2025.
  • In the past 5 years, Agios Pharmaceuticals' Prepaid Assets ranged from a high of $46.5 million in Q3 2022 and a low of $19.5 million during Q1 2021
  • Moreover, its 5-year median value for Prepaid Assets was $39.6 million (2021), whereas its average is $38.1 million.
  • Data for Agios Pharmaceuticals' Prepaid Assets shows a peak YoY increase of 15070.8% (in 2021) and a maximum YoY decrease of 3307.15% (in 2021) over the last 5 years.
  • Over the past 5 years, Agios Pharmaceuticals' Prepaid Assets (Quarter) stood at $39.8 million in 2021, then decreased by 2.21% to $39.0 million in 2022, then fell by 10.1% to $35.0 million in 2023, then rose by 14.69% to $40.2 million in 2024, then rose by 9.87% to $44.1 million in 2025.
  • Its Prepaid Assets stands at $44.1 million for Q4 2025, versus $43.2 million for Q3 2025 and $44.7 million for Q2 2025.